Key result
Mylk3 variant abolishes cardiac MLCK3 protein in C57BL/6N mice, while ~35% of studies omit substrain.
Why the study?
Genetic variation among C57BL/6 mouse strains may influence cardiovascular phenotypes and contribute to inter-study variability, motivating an investigation into the distribution of the cardiomyopathy-linked Mylk3 c.-5T>A variant across C57BL/6 lineages.
The Mylk3 c.-5T>A variant causing loss of full-length cardiac MLCK3 and late-onset dilated cardiomyopathy is a lineage-defining feature across C57BL/6N and C57BL/6By mouse substrains, highlighting a critical confounding factor in preclinical cardiovascular research given that 35% of recent studies fail to report which C57BL/6 substrain was used.
Answers are grounded in this paper and cite their sources.
C57BL/6 substrain variants may confound cardiac phenotypes in models; leaves open the need for standardized substrain reporting in preclinical research.
Genetic variation among C57BL/6 mouse strains may influence cardiovascular phenotypes and contribute to inter-study variability in biomedical research. We investigated the distribution of the Mylk3 c.-5T>A variant, previously shown to cause loss of cardiac myosin light-chain kinase (MLCK3) and late-onset dilated cardiomyopathy, across C57BL/6 lineages. The variant was homozygously present in C57BL/6N and C57BL/6By strains but absent from C57BL/6J-derived mouse strains. This distribution indicates that the variant was established before divergence of the C57BL/6By branch, although its precise origin cannot be determined from contemporary samples. Despite preserved Mylk3 transcript abundance, C57BL/6N hearts lacked full-length MLCK3 protein. These findings exemplify how genetic differences between seemingly identical wild-type backgrounds can introduce significant confounding factors, highlighting the importance of accurate substrain identification and reporting for experimental design, interpretation, and reproducibility. Highlighting the broader relevance of these findings, a survey of 1238 recent open-access articles from cardiovascular journals found that 35% reported the use of C57BL/6 mice without specifying the N or J substrain. Altogether, our findings identify the Mylk3 variant as a lineage-defining feature of C57BL/6N mice and related substrains, with potential implications for cardiovascular studies using this background.
No takes yet. Share an insight, caveat, or question.
Goktas et al. (2026) studied Mylk3 c.-5T>A variant associated with loss of full-length MLCK3 and late-onset dilated cardiomyopathy. C57BL/6N and C57BL/6By mouse substrain lineage (Mylk3 c.-5T>A variant) vs. C57BL/6J-derived mouse substrains was evaluated on Presence of homozygous Mylk3 c.-5T>A variant and cardiac expression of full-length MLCK3 protein and Mylk3 mRNA (p=0.640). The Mylk3 c.-5T>A variant is fixed across C57BL/6N and C57BL/6By mice, abolishing full-length cardiac MLCK3 protein despite preserved mRNA, while 35% of 1,238 papers omitted substrain.
Synapse has enriched 10 related papers. Consider them for comparative context: